10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · page 18 of 27
Includes sensitivity tables for WACC vs Terminal EBITDA Multiple, WACC vs Implied Perpetuity Growth Rate, and WACC vs Terminal Value as a % of Enterprise Value.
Deck · appendix_data · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
annotation 1/1 table 5/5 title 1/1
Components 7
source-note scenario scenario scenario scenario valuation headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1